Value of functional in-vivo endpoints in preclinical radiation research

Berit Kummer, Steffen Loeck, Kristin Gurtner, Nadine Hermann, Ala Yaromina, Wolfgang Eicheler, Michael Baumann, Mechthild Krause*, Christina Jentsch

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)155-161
Number of pages7
JournalRadiotherapy and Oncology
Volume158
DOIs
Publication statusPublished - May 2021

Keywords

  • Neoplasms
  • Irradiation
  • Combined modality therapy
  • Preclinical research
  • Xenografts
  • EGFR
  • SQUAMOUS-CELL CARCINOMA
  • CANCER STEM-CELLS
  • LOCAL TUMOR-CONTROL
  • FRACTIONATED-IRRADIATION
  • RADIOTHERAPY
  • INHIBITION
  • EXPRESSION
  • LINES
  • RADIOSENSITIVITY

Cite this